A Clinical Study of Multiple Primary Malignancies in Patients Treated for Cervical Carcinoma.
- Author:
Young Sook JEON
1
;
Byoung Taek KIM
;
Kyung Hwa YI
;
Suck Chul CHOI
;
Jong Hoon KIM
;
Byoung Gie KIM
;
Sang Yoon PARK
;
Eui Don LEE
;
Kyeong Hee LEE
;
Kee Bock PARK
Author Information
1. Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea.
- Publication Type:Original Article
- Keywords:
Cervical cancer;
Multiple primary malignancy;
Malignant mixed Mllerian tumor;
surveillance
- MeSH:
Adenocarcinoma;
Follow-Up Studies;
Humans;
Mass Screening;
Medical Records;
Neoplasms, Second Primary;
Rectal Neoplasms;
Retrospective Studies;
Sarcoma, Endometrial Stromal;
Telephone;
Urinary Bladder Neoplasms;
Uterine Cervical Neoplasms;
Uterus
- From:Korean Journal of Obstetrics and Gynecology
1997;40(9):1999-2007
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Knowledge about the degree of risk and location of multiple primary cancers can facilitate the targeting of screening and surveillance practices on follow-up after treatment of cervical cancer. PURPOSE: The retrospective study was performed to evaluate the characteristics of multiple primary malignancies in patients treated for cervical carcinoma. METHOD: From data base file of gynecologic cancer patients between 1976 and 1995, total 20 patients were found to have cervical cancer and another primary malignancy. Their medical records and pathologic slides were reviewed. Follow-up information was obtained from medical records or by telephone. RESULT: There were 8 synchronous and 12 metachronous multiple primary cancers (MPC) among 20 patients. Their mean age was 51 years (range 23 ~ 68 years). The distribution of FIGO stage of the patients with cervical cancer was classified into stage I, 6 patients; stage II, 9 ; and stage III, 5. All patients showed squamous cell type histology of cervical cancer. Eight(40 %) of 20 patients developed second cancer in uterus : 6 malignant mixed Mllerian tumors(MMMT), one endometrial stromal sarcoma, and one endometrial adenocarcinoma. Seven of 8 synchronous type MPC patients are alive (median follow-up, 27 months). In contrast, only one out of 12 metachronous type MPC patients is alive(median follow-up, 114 months). The occurrence of eight malignancies including 6 MMMT, one bladder cancer, and one rectal cancer might be related with previous radiation therapy for cervical cancer. CONCLUSION: These results suggest that routine screening and surveillance work-up might not be necessary in most of patients with cervical cancer. However, the patients with cervical cancer undergoing radiation treatment have to be followed carefully with the consideration of possibility for developing second cancer in the field of irradiation.
